SBOMs and Medical Device Vulnerability Management
Post Summary
Medical devices rely on complex software, often containing hundreds of third-party components. Managing vulnerabilities in these systems is a challenge. The Software Bill of Materials (SBOM) is a tool that provides a detailed inventory of software components, enabling faster, automated vulnerability detection and compliance with evolving FDA regulations. Unlike older manual methods, SBOMs allow for real-time monitoring, better supply chain visibility, and streamlined risk management.
Key takeaways:
- SBOMs improve detection speed: Automated scans identify vulnerabilities in minutes, compared to days or weeks with manual processes.
- Enhanced supply chain visibility: SBOMs map all components and dependencies, reducing hidden risks.
- Compliance-ready: SBOMs meet FDA's new cybersecurity requirements for internet-connected devices.
- Efficient remediation: Continuous updates and automated processes reduce response times and resource needs.
Practical Guide to Cybersecurity and SBOM Management for FDA Approval
sbb-itb-535baee
1. Conventional Vulnerability Management
In the past, manufacturers relied heavily on manual processes and basic SOUP (Software of Unknown Provenance) lists, as outlined in IEC 62304, to manage software components. These lists lacked detail about dependencies or supply chain hierarchies. While sufficient for basic compliance, this approach struggles to keep pace with today’s interconnected healthcare systems, significantly affecting how quickly vulnerabilities are detected and addressed.
Vulnerability Detection Speed
On average, identifying vulnerabilities in third-party components takes 30 to 90 days. This process often involves manually cross-referencing vendor bulletins with databases like the National Vulnerability Database (NVD). In some cases, reverse-engineering is necessary to pinpoint which components are affected. A glaring example of this inefficiency was the 2017 WannaCry attack. Remediation efforts for unpatched imaging device software were delayed for weeks as unknown dependencies and validation requirements complicated the process[8]. Research underscores the scale of the issue: 70% of medical device software contains open-source components that are not actively tracked[2][13].
Supply Chain Visibility
The lack of detailed inventory tracking further compounds the problem. Traditional SOUP lists only document surface-level information, such as direct components, while ignoring nested dependencies and upstream sources[2][5]. This lack of visibility is particularly concerning given that modern medical devices can include anywhere from 200 to 500 third-party components, each with its own web of dependencies. According to experts at the Johner Institute, without detailed hierarchical mapping, SOUP lists fail to account for "system components around the device", leaving vulnerabilities in connected IT networks unaddressed and potentially jeopardizing critical device functions[5]. As a result, healthcare providers often have limited ability to assess devices for outdated software or third-party cybersecurity risks before purchasing, relying entirely on manufacturer disclosures instead[7].
Regulatory Compliance
While manual risk assessments and SOUP documentation meet the requirements of IEC 62304, they fall short under the FDA’s 2023 cybersecurity rules for "cyber devices." These regulations demand far greater transparency and detail about software components[3][5][6]. As Matt Christensen, Sr. Director of GRC at Intermountain Health, aptly explains:
"Healthcare is the most complex industry... You can't just take a tool and apply it to healthcare if it wasn't built specifically for healthcare"[1].
Spreadsheet-based tracking systems not only increase the burden of audits but also fail to provide the machine-readable formats that regulators now expect.
Postmarket Remediation Efficiency
Addressing vulnerabilities postmarket is a time-consuming and resource-intensive process. It involves monitoring, verification, risk analysis, testing, and reporting to the FDA, which can take more than 100 hours per incident. Worse still, device revalidation under FDA Quality System Regulation can stretch this timeline to 6 to 12 months[6]. Case studies from the NTIA’s 2019 healthcare proof-of-concept highlighted how untraceable components led to prolonged exposure periods, leaving healthcare delivery organizations vulnerable for extended durations[12][2].
2. SBOM-Based Vulnerability Management
Software Bill of Materials (SBOMs) play a key role in automating vulnerability management. By offering a machine-readable inventory, SBOMs allow healthcare organizations and manufacturers to tackle threats quickly and accurately.
Vulnerability Detection Speed
SBOMs make vulnerability detection faster by enabling automated scans against CVE databases. When a new vulnerability is announced, teams can use the SBOM to pinpoint affected components in just minutes instead of spending days - or even weeks - on manual reviews [2]. A prime example is the Log4Shell vulnerability (CVE-2021-44228), where manufacturers used SBOMs to verify library versions across their entire device fleets. This approach enabled them to patch vulnerable devices within hours, preventing potential exploits [4]. This speed also benefits broader healthcare supply chain security challenges.
Supply Chain Visibility
SBOMs provide a detailed view of the software supply chain, mapping out components, dependencies, versions, suppliers, and licenses across all layers of software [5]. This level of visibility helps uncover hidden vulnerabilities that may stem from deeply embedded third-party code. For devices containing hundreds of components, this mapping allows manufacturers to trace risks throughout the ecosystem [2]. Think of SBOMs as a "nutrition label" for software, helping organizations assess their risk exposure [8].
Regulatory Compliance
SBOMs are also essential for meeting FDA requirements for Section 524B cyber devices - medical devices that rely on software and are internet-enabled. Starting in June 2025, manufacturers will need to include SBOMs in 510(k), De Novo, and PMA applications, adhering to NTIA baseline attributes like component name, version, supplier, and unique identifiers [2][3]. The FDA allows vulnerability data to be included either within the SBOM itself or as a separate addendum, cross-referenced with CISA's Known Exploited Vulnerabilities Catalog [6]. This machine-readable format reduces the manual burden of audits while ensuring transparency for both premarket and postmarket processes, aligning with IMDRF recommendations and IEC TR 60601-4-5 standards for cybersecurity [7]. These compliance measures streamline risk management efforts.
Postmarket Remediation Efficiency
When integrated into continuous build processes, SBOMs support ongoing vulnerability monitoring throughout a device's lifecycle. Instead of being a static document created at launch, SBOMs can be updated automatically with every software release, allowing for continuous CVE scanning [4]. This method speeds up remediation by quickly identifying affected units and prioritizing fixes based on risk severity. For long-lived medical devices, this approach ensures timely patching or the deployment of countermeasures without requiring full device replacements. It’s a practical way to maintain device cybersecurity over time.
Advantages and Disadvantages
Conventional vs SBOM-Based Medical Device Vulnerability Management Comparison
This section dives into the trade-offs between traditional vulnerability management methods and the newer SBOM-based approaches. By comparing their strengths and weaknesses, we can better understand how each method addresses software security challenges.
Conventional methods often rely on manual processes like questionnaires and spreadsheets. These approaches demand significant time and effort, as organizations frequently need to chase vendors for updates [1]. This lack of efficiency also limits visibility, making it hard to uncover medical device security risks hidden within software components.
On the other hand, SBOM-based methods leverage automation to speed up vulnerability detection. By using tools like automated CVE scanning, they offer detailed insights into software components, including open-source libraries and third-party dependencies [14]. Standards such as CycloneDX (ECMA-424) and Vulnerability Exploitability Exchange (VEX) further enhance accuracy by identifying whether specific vulnerabilities are exploitable in a given context [14]. Additionally, this approach simplifies compliance with FDA and international cybersecurity standards [14].
The benefits of SBOM integration are clear in practice. For instance, Tower Health managed to reduce its risk assessment team from three full-time employees (FTEs) to two, all while performing more assessments. Terry Grogan, CISO at Tower Health, highlighted this efficiency:
"Censinet RiskOps allowed 3 FTEs to go back to their real jobs! Now we do a lot more risk assessments with only 2 FTEs required" [1].
This comparison illustrates how SBOM-based approaches not only streamline regulatory compliance but also enhance the efficiency of vulnerability management.
| Metric | Conventional Methods | SBOM-Based Methods |
|---|---|---|
| Detection Speed | Slow; relies on manual questionnaires and periodic scans [1] | Rapid; automated CVE database matching [14] |
| Visibility | Limited; restricted to vendor disclosures [1] | Comprehensive; includes all components and sub-dependencies [14] |
| Compliance | Ad-hoc; managed via spreadsheets and non-standardized forms [1] | Standardized; meets ECMA-424 and FDA requirements [14] |
| Remediation Efficiency | Low; difficult to assess sub-component impact | High; VEX filters non-exploitable vulnerabilities [14] |
SBOM Integration with Risk Management Platforms
Modern medical devices are complex, often containing anywhere from 200 to 500 third-party components. Each of these components could introduce vulnerabilities that put patient safety and data security at risk [4]. For healthcare delivery organizations, managing this complexity through spreadsheets or manual processes is no longer practical. Platforms like Censinet RiskOps™ are changing the game by automating SBOM (Software Bill of Materials)-driven vulnerability management. These platforms ingest and analyze machine-readable SBOMs from vendors, map components to known CVEs (Common Vulnerabilities and Exposures), and help prioritize risks across interconnected medical devices [2].
Streamlining Vulnerability Detection
Automation is a key strength of platforms like Censinet RiskOps™. When a new CVE is disclosed, the platform scans SBOM inventories, matches components to CVE databases, and sends real-time alerts for affected devices. This process, which once took days of manual effort, now takes minutes. The result? Continuous monitoring and management of "living" SBOMs throughout a device's lifecycle [4][6]. This efficiency has been shown to reduce the need for full-time staff while increasing the number of assessments completed.
AI-Powered Risk Assessments
Censinet RiskOps™ also leverages AI-powered risk assessments to go deeper. Its GRC AI™ and Assessor Agents analyze SBOM hierarchies to predict how vulnerabilities might cascade through dependencies. For example, a single open-source library could impact multiple device functions. These tools provide contextual risk scores by combining SBOM data with exploitability metrics. This enables healthcare organizations to prioritize patches for high-risk devices, ensuring compliance with FDA §524B requirements [3][10]. By blending automation with team collaboration, these AI-driven insights make the vulnerability management process more effective and focused.
Collaboration for Better Risk Management
Managing medical device risks isn’t a solo effort - it requires collaboration. Censinet RiskOps™ facilitates secure, standardized SBOM sharing, allowing manufacturers and healthcare providers to work together on vulnerability triage [7]. The platform also automates notifications for components reaching end-of-life, tracks remediation progress, and enables shared risk scoring. This collaborative approach ensures that all stakeholders stay aligned throughout the device lifecycle [9].
Measurable Impact
The integration of SBOMs with risk management platforms delivers measurable results. Automation can cut vulnerability response times by up to 80% and identify 90% of new CVEs before they can be exploited in connected ecosystems [2][4]. For healthcare organizations, this unified visibility into supply chain vulnerabilities is essential for safeguarding patient data, clinical applications, and medical devices while meeting regulatory requirements. It’s a critical step toward ensuring both compliance and patient safety.
Conclusion
SBOM-based approaches significantly strengthen the protection of medical devices and patient data. Traditional manual methods often fall short, especially with modern devices that contain hundreds of third-party components. A single CVE in one of these components can ripple across multiple functions, creating widespread vulnerabilities [2][4]. SBOMs provide the visibility needed to quickly pinpoint which devices are affected by new vulnerabilities, enabling precise, efficient responses instead of lengthy manual investigations.
When SBOMs are treated as dynamic elements of continuous build processes, they enable ongoing monitoring throughout a device's lifecycle - from premarket submissions to postmarket oversight [4][7]. This approach aligns with FDA Section 524B requirements and EU MDR/ISO 14971 standards, ensuring compliance with key regulatory frameworks [10][11]. Additionally, machine-readable formats like SPDX and CycloneDX allow for automated vulnerability scanning, cutting response times - a critical advantage as regulatory demands grow and software supply chain threats become more complex.
Healthcare organizations should take these advancements further by automating SBOM updates with every release, integrating them into vulnerability management programs (including checks against the CISA KEV catalog), and using them to assess device risks before making purchasing decisions [7][6]. Matt Christensen, Sr. Director GRC at Intermountain Health, emphasizes the unique challenges of healthcare:
"Healthcare is the most complex industry... You can't just take a tool and apply it to healthcare if it wasn't built specifically for healthcare" [1].
Purpose-built platforms that can ingest machine-readable SBOMs and map CVEs in real time are crucial for managing the complexity of today’s medical device ecosystems. Tools like Censinet RiskOps™ demonstrate how integrating SBOM data into continuous risk management workflows can deliver actionable insights and faster responses.
Integrating SBOMs improves both cybersecurity and regulatory compliance, while fostering the collaborative risk management needed for the long lifespans of medical devices. Organizations that adopt these practices now will be better prepared to meet evolving FDA requirements, safeguard patient safety, and maintain oversight of supply chain vulnerabilities across their entire device inventory.
FAQs
What should a medical device SBOM include?
A medical device SBOM (Software Bill of Materials) is essentially a machine-readable inventory of all the software components within a device. This includes everything from third-party libraries to proprietary code. It should clearly outline critical details like the supplier's name, version numbers, dependencies, support levels, and lifecycle information. This level of detail helps maintain transparency, strengthens security measures, and ensures compliance with FDA regulations.
How do SBOMs and VEX work together to reduce false vulnerability alerts?
SBOMs and VEX work hand in hand to reduce unnecessary vulnerability alerts by offering precise details about whether a vulnerability genuinely impacts a system. VEX helps cut through false positives by leveraging data from SBOMs to determine if vulnerabilities are actually accessible or exploitable, delivering clearer and more actionable insights.
How can hospitals use SBOMs before buying or deploying a device?
Hospitals can leverage Software Bill of Materials (SBOMs) to strengthen their cybersecurity measures and meet compliance requirements when acquiring or deploying medical devices. An SBOM acts as a comprehensive list of all software components within a device, making it easier to spot potential vulnerabilities, evaluate security risks, and ensure adherence to FDA regulations.
By incorporating SBOMs into the procurement process, hospitals can:
- Identify security risks: Analyze software components for known vulnerabilities before purchase.
- Ensure regulatory compliance: Verify that devices meet necessary standards, including FDA guidelines.
- Manage vulnerabilities proactively: Track and address risks throughout the device's lifecycle.
This approach not only helps protect patient safety but also simplifies decision-making by providing clear insights into a device's security profile.
